| Aktie | Ticker | Breite | GCS | 2025/Q4 | |||
|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 223.585.499 $ | +223.585.499 $ | 25 | |||||
| RELMADA THERAPEUTICS, INC. | RLMD | → 0 | Neutral | 32.361.000 $ | +32.361.000 $ | 1 | |
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 27.705.600 $ | +27.705.600 $ | 1 | |
| Maze Therapeutics, Inc. | MAZE | → 0 | Schwach | 20.300.700 $ | +20.300.700 $ | 1 | |
| Abivax S.A. | ABVX | → 0 | Schwach | 19.553.975 $ | +19.553.975 $ | 1 | |
| KalVista Pharmaceuticals, Inc. | KALV | → 0 | 11.305.000 $ | +11.305.000 $ | 1 | ||
| PALISADE BIO, INC. | PALI | → 0 | Neutral | 10.575.000 $ | +10.575.000 $ | 1 | |
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Stark | 8.685.250 $ | +8.685.250 $ | 1 | |
| Inhibikase Therapeutics, Inc. | IKT | → 0 | Neutral | 8.661.250 $ | +8.661.250 $ | 1 | |
| Kodiak Sciences Inc. | KOD | → 0 | Schwach | 8.156.212 $ | +8.156.212 $ | 1 | |
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 7.676.000 $ | +7.676.000 $ | 1 | ||
| ArriVent BioPharma, Inc. | AVBP | → 0 | Schwach | 6.800.560 $ | +6.800.560 $ | 1 | |
| Tarsus Pharmaceuticals, Inc. | TARS | → 0 | Schwach | 6.550.400 $ | +6.550.400 $ | 1 | |
| Upstream Bio, Inc. | UPB | → 0 | Neutral | 6.262.148 $ | +6.262.148 $ | 1 | |
| SPRUCE BIOSCIENCES, INC. | SPRB | → 0 | Schwach | 6.097.700 $ | +6.097.700 $ | 1 | |
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 4.730.796 $ | +4.730.796 $ | 1 | |
| DBV Technologies S.A. | DBVT | → 0 | Neutral | 4.600.800 $ | +4.600.800 $ | 1 | |
| CYBIN INC. | HELP | → 0 | Neutral | 4.294.500 $ | +4.294.500 $ | 1 | |
| Lipocine Inc. | LPCN | → 0 | 4.255.900 $ | +4.255.900 $ | 1 | ||
| BELITE BIO, INC | BLTE | → 0 | Sehr stark | 4.158.960 $ | +4.158.960 $ | 1 | |
| GH Research PLC | GHRS | → 0 | 4.000.500 $ | +4.000.500 $ | 1 | ||
| EUPRAXIA PHARMACEUTICALS INC. | EPRX | → 0 | Stark | 3.775.000 $ | +3.775.000 $ | 1 | |
| Ventyx Biosciences, Inc. | VTYX | → 0 | 3.702.300 $ | +3.702.300 $ | 1 | ||
| NextCure, Inc. | NXTC | → 0 | Schwach | 3.362.548 $ | +3.362.548 $ | 1 | |
| Vera Therapeutics, Inc. | VERA | → 0 | Neutral | 3.038.400 $ | +3.038.400 $ | 1 | |
| Wave Life Sciences Ltd. | WVE | → 0 | Neutral | 2.975.000 $ | +2.975.000 $ | 1 | |
| 223.585.499 $ | +223.585.499 $ | 25 | |||||